OTCMKTS:SFOSF Shanghai Fosun Pharmaceutical (Group) (SFOSF) Stock Price, News & Analysis $2.14 0.00 (0.00%) As of 11/13/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Shanghai Fosun Pharmaceutical (Group) Stock (OTCMKTS:SFOSF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SFOSF alerts:Sign Up Key Stats Today's Range$2.14▼$2.1450-Day Range$1.93▼$2.4552-Week Range$1.93▼$2.86Volume8 shsAverage Volume1,237 shsMarket CapitalizationN/AP/E Ratio1.83Dividend Yield12.62%Price TargetN/AConsensus RatingN/A Company Overview Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based healthcare company founded in 1994 and headquartered in Shanghai. Its business spans pharmaceutical research and development, manufacturing and sales, as well as medical devices, diagnostics and healthcare services. The company develops and markets medicines in areas that include oncology, cardiovascular and metabolic diseases, and infectious diseases. Its portfolio also includes biological medicines and other pharmaceutical products, alongside diagnostic products and medical equipment. Fosun Pharma serves customers in China and international markets through its own operations and partnerships. It has expanded beyond pharmaceuticals into healthcare services, including hospital-related businesses, as part of its broader healthcare platform.AI Generated. May Contain Errors. Read More Receive SFOSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shanghai Fosun Pharmaceutical (Group) and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SFOSF Stock News HeadlinesFosun Pharma Sets October Board Meeting to Approve Q3 ResultsOctober 12, 2026 | tipranks.comShanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) Q2 2026 Earnings Call TranscriptSeptember 28, 2026 | seekingalpha.comURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards urges homeowners to check the map and see whether one is near them. Families in Georgia have been forced to sell, entire Ohio neighborhoods are being torn down, and nearly 50,000 Lake Tahoe residents face losing power. Rickards advised the Pentagon and the U.S. intelligence community for decades. He says one man outside Washington can stop it.November 14 at 1:00 AM | Paradigm Press (Ad)Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 BillionSeptember 6, 2026 | prnewswire.comShanghai Fosun Pharma Executes HK$3.6 Million H-Share BuybackAugust 27, 2026 | tipranks.comFosun Pharma Sets August Board Meeting to Approve 2026 Interim ResultsAugust 13, 2026 | tipranks.comFosun Pharma Subsidiary Wins Approval for New Type 2 Diabetes Combination DrugAugust 3, 2026 | tipranks.comFosun Pharma Sets Final 2025 Dividend and Withholding Tax Terms for H-Share InvestorsJune 16, 2026 | tipranks.comSee More Headlines SFOSF Stock Analysis - Frequently Asked Questions How have SFOSF shares performed this year? Shanghai Fosun Pharmaceutical (Group)'s stock was trading at $2.50 at the start of the year. Since then, SFOSF stock has decreased by 14.4% and is now trading at $2.14. How do I buy shares of Shanghai Fosun Pharmaceutical (Group)? Shares of SFOSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:SFOSF CIKN/A Webwww.fosunpharma.com Phone86-21-3398-7000FaxN/AEmployees40,603Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio1.83 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:SFOSF) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredElon wants to move AI off the planet. Amazon isn't ready.What if the next AI race isn't on Earth? Tim Bohen's Mission X presentation explores Elon Musk's idea of movin...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shanghai Fosun Pharmaceutical (Group) With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
